Cellular biology of prostatic growth factors

D M Peehl1

  • 1Department of Urology, Stanford University School of Medicine, California, USA.

The Prostate. Supplement
|January 1, 1996
PubMed

Insights

The causes of prostate cancer and benign prostatic hyperplasia (BPH) remain unclear. Understanding growth factor roles and pathways is key to developing new prevention and treatment strategies.

Area of Science:

  • Urology
  • Oncology
  • Cell Biology

Background:

  • The etiology of prostate cancer and benign prostatic hyperplasia (BPH) is largely unknown.
  • Growth factors and their receptors are implicated in the development of these prostatic conditions.
  • Dysregulation of cell proliferation and differentiation contributes to malignant or hyperplastic phenotypes.

Purpose of the Study:

  • To investigate the role of growth factors in prostatic diseases.
  • To explore the expression and interaction of growth factors within prostatic cells.
  • To define autocrine, paracrine, and endocrine growth regulation pathways in the human prostate.

Main Methods:

  • Utilized cell culture techniques to study growth factor expression and interactions.
  • Employed immunohistochemistry and in situ hybridization to correlate growth factor expression with histopathology.

Main Results:

  • Cell culture provided insights into growth factor expression and interactions in prostatic cells.
  • Immunohistochemistry and in situ hybridization visualized growth factor expression alongside histopathological features.

Conclusions:

  • Further understanding of growth factor pathways is essential for advancing prostate cancer and BPH research.
  • Defining specific regulatory pathways will aid in developing novel preventative, diagnostic, and therapeutic strategies for prostatic diseases.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...